Wake Forest Baptist Health, Section on Hematology & Oncology is a clinical research site located in Winston-Salem, North Carolina, United States 27157.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Wake Forest Baptist Health, Section on Hematology & Oncology has participated in 1 clinical trials.
Therapeutic areas: Newly Diagnosed FLT3 Mutated AML.
Sponsors: Arog Pharmaceuticals, Inc..
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Wake Forest Baptist Health, Section on Hematology & Oncology has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Wake Forest Baptist Health, Section on Hematology & Oncology has 1 clinical trials on record. Their work covers Newly Diagnosed FLT3 Mutated AML.
Wake Forest Baptist Health, Section on Hematology & Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.